Raymond James Downgrades Meridian Bioscience To Underperform

Analysts at Raymond James downgraded Meridian Bioscience, Inc. VIVO from Market Perform to Underperform. Meridian Bioscience shares have dropped 36.96% over the past 52 weeks, while the S&P 500 index has gained 12.39% in the same period. Meridian Bioscience's shares rose 0.86% to close at $16.46 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsRaymond James
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!